Int J Pharm Pharm Sci, Vol 8, Issue 1, 462-463Short Communication



Faculty of Pharmacy Sanata Dharma University, Yogyakarta, Indonesia
Email: [email protected]

 Received: 19 Oct 2015 Revised and Accepted: 02 Dec 2015


Objective:Macaranga tanarius showed a potent α–glucosidase inhibitors that may benefit diabetes treatment. The hexane-ethanol fraction of methanol extract of Macaranga tanarius was investigated for antidiabetic, and anti hiperlidemia activity in rats feed with high glucose-fructose diet.

Methods:After induced with high glucose-fructose diet for 42 d, the rats were treated with the hexane-ethanol fraction of methanol extract of Macaranga tanarius at doses of 34.2, 78.5, 137 mg/kg per oral once in a day for 5 d and high glucose-fructose diet consecutively. Fasting blood glucose, cholesterol, triglyceride, HDL and LDL concentration were evaluated at the next day after treatment.

Results:The 5 d administration of hexane-ethanol fraction of methanol extract of Macaranga tanarius did not produce any significant difference in any of the assigned parameters between the diet and all dose groups.

Conclusion:The hexane-ethanol fraction of methanol extract of Macaranga tanariusat all level has not antidiabetic and anti hiperlidemia activity in rats feet with high glucose-fructose diet.

Keywords:Macaranga tanarius, antidiabetic, Antihiperlipedmia, Glucose-fructose.

It is known that many diabetics have hypercholesterolemia and hypertriglyceridemia. At present, the importance of looking not only for possible glucose-lowering drugs but also lipid lowering drugs to be given as adjuvant therapy in the treatment of diabetic patients [1].

Macarangatanarius (Euphorbiaceae) is a very fast-growing species and well known as an ant-plant defended by ants against herbivores [2]. It has been reported that isolated compounds of Macarangatanarius had cytotoxic, antioxidant activities as well as inhibitory activity against a cycloxygenase-2 test system and 2,2-diphenyl-picrylhydrazyl (DPPH) radical scavenging activity [3-5]. Invitro study showed that the isolated ellagitannin and chebulagic acid of Macarangatanarius inhibited α-glucosidase and intestinal maltase that may benefit diabetes treatment [6]. Based on Marvin Sketch software, ellagitanin and chebulagic acid of Macaranga tanarius have a similar lipophilic character as hexane-ethanol 50:50. Therefore, it is crucial to evaluate the antidiabetic and anti-hyperlipidemia activities of a hexane-ethanol fraction of methanol extract of Macarangatanarius against high glucose-fructose diet in rats.

The fresh leaves of Macarangatanarius were collected from Sleman Yogyakarta Indonesia and were identified and authenticated using descriptive literature. A voucher specimen was deposited in the Laboratory of Pharmaceutical Biology, Pharmacy Faculty, Sanata Dharma University, and Yogyakarta, Indonesia. Dried leaves of Macarangatanarius were extracted with 50% aqueous methanol for 24h at room temperature. The crude extract was extracted with hexane-ethanol 50:50 for 24 h at room temperature. The resulting suspension was filtered and was evaporated by vaccum rotary evaporator at 50 oC to yield a solid residue of a hexane-ethanol fraction of methanol extract of Macarangatanarius (HEMM) (yield 3.51%).

Adult male Wistar rats (180-250g) were used in this study. The animals were obtained from the Imono Laboratory of Pharmacy Faculty of Sanata Dharma University, Indonesia. The animals were maintained under standard laboratory condition. They were housed in standard cages (five animals per cage) at a temperature of 22o±2oC and 12:12h light-dark cycle. The animals were provided with pelleted diet and water ad libitum. The experimental protocol and procedures used in this study were approved by The Medical and Health Research Ethics Committee (MHREC) Faculty of Medicine Gadjah Mada University Indonesia. Healthy rats were weighed and randomly divided into 5 groups of 5 animals in each. Group 1 was treated with normal diet (BR2) for 47 d. Group 2-5received high glucose-fructose for 42 d. After induction for 42d, group 2 received CMC as the vehicle and high glucose-fructose for 5 d, whereas group 3-5 received HEMM at doses of 34.2, 78.5, 137 mg/kg per oral once in a day for 5 d and high glucose-fructose diet consecutively. Blood for biochemical analysis from all groups was obtained by sinus orbitals after 24 h administration. Parameters of blood biochemical such as fasting blood glucose, cholesterol, triglyceride, HDL, LDL were measured. Results were analyses by one-way analysis of variance (ANOVA) and followed by Tukey HSD test for multiple comparisons of clinical pathology parameters. The significant difference was considered at P<0.05.

In order to establish a scientific basic for the utilization hexane-ethanol fraction of methanol extract of Macarangatanarius (HEMM) in the treatment of diabetes, it was decided to evaluate the antidiabetic and anti-hyperlipidemia in high glucose-fructose feed in rats. Fructose-feed in animal models are frequently induce insulin resistance, impaired glucose tolerance, hyperinsulinemia, hyper-tension and hyperlipidemia [7-10]

Our present study showed that the high glucose-fructose feed possesses definite hypertriglyceridemic and hyperglycemic after 42 d of treatment as revealed in the table (1). The levels of triglyceride and fasting blood glucose were found significantly increased in high feed glucose-fructose diet rats for 42 d when compared with the normal diet (P<0.05). The HDL levels of high feed glucose and fructose diet decreased significantly as compared to the normal diet. No significant increase on cholesterol levels was observed between high feed glucose-fructose diet as compared to normal diet. LDL levels did not significantly affected by high feed glucose-fructose diet when compared to normal diet. Hypertriglyceridemia and low plasma concentration of HDL comprise the typical dyslipidemia of insulin resistant state and type 2 diabetes. The interaction between HDL that is triglyceride-enriched and hepatic lipase action plays an important role in the enhanced catabolism of HDL in insulin resistant and hypertriglyceridemic states [11]. Huang et al. reported that the adverse effect of fructose on hepatic lipid metabolism, even by low concentration of fructose. Fructose leads to increased de novo hepatic fatty acid synthesis and release of triglycerides in comparison to glucose [12]. Glucose and fructose transporter, GLUT8, is reported for hepatocyte fructose transport and fructose-induced macrosteatosis [13].

Previous studies have shown that serum triglyceride levels were increased to rates of feeding fructose diet for 3 and 8 w. However after 8 w of feeding, the blood glucose levels were increased significantly compared to a control diet [14].

Table 1: Effectofhexane-ethanol fraction of methanol extract of Macarangatanarius (HEMM) on cholesterol, triglyceride, HDL, LDL and blood glucose in rats feeds with high glucose-fructose (GF) diets


Cholesterol (mmol/l)

Trigliyceride (mmol/l)





FastingBlood Glucose (mmol/l)

Normal diet












GF+HEMM 34.2 mg/kg






GF+HEMM 68.5 mg/kg






GF+HEMM 137 mg/kg






Values are mean±S. E. M., n = 5 animals per group, a: P<0.05 compared with the normal diet, b: P<0.05 compared with the GF+CMC

There was no significant reduction of the levels of triglyceride and fasting blood glucose in the rats administered 34.2, 78.5, 137 mg/kg of HEMM. In addition, the HDL level was not elevated significantly after HEMM administration. The preliminary phytochemical screening of isolated compounds of Macarangatanarius supports its inhibitory effect on α-glucosidase and intestinal maltase [6]. In addition, another report mentioned that methanol-water extract of Macarangatanarius at dose 0.43; 1.28 and 3.84 mg/kg was effective in improving oral glucose tolerance [15].

However, administration of HEMM 34.2, 78.5, 137 mg/kg for 5 d to rats feed with glucose-fructose diet did not bring the levels of fasting glucose, triglyceride, and HDL into the normal range. This clearly indicates that HEMM has not antidiabetic and anti-hyperlipidemia activities. The time period of administration likely to be responsible for these results.  The overall results of the present study indicate the hexane-ethanol fraction of methanol extract of Macarangatanarius (HEMM) at three dose levels (34.2; 78.5; 137 mg/kg) for 5 d has not antidiabetic and anti-hyperlipidemia activity in rats feet with high glucose-fructose diet.


This research project was supported by a grant from Directorate General of Higher Education, Ministry of Education and Culture Indonesia with contract number: 024/Penel. LPPM/III/2015.


The author(s) declared no conflicts of interest with respect to the authorship and/or publication.


  1. Su DHW, Yeo KT. Diabetic retinopathy and serum lipids. Singapore Med J 2000;41:295-7.
  2. World Agroforestry Centre. Botanic Nomenclature to Agroforestry trees: Macarangatanarius. World Agroforestry Centre; 2011. Available: http://www.worldagroforestrycentre. org/sea/Products/AFDbases/af/asp/SpeciesInfo. asp?SpID=1092. [Last accessed on 12 Mar 2011].
  3. Phommart S, Sutthivaiyakit P, Chimnoi N, Ruchirawat S, Sutthivaiyakit S. Constituents of the leaves of macarangatanarius. J Nat Prod 2005;68:927-30.
  4. Matsunami K, Takamori I, Shinzato T, Aramoto M, Kondo K, Otsuka H. Radical-Scavenging activities of new mega stig mane glucosides from Macarangatanarius(L.) MÜLL.-ARG. Chem Pharm Bull 2006;54:1403-7.
  5. Matsunami K, Otsuka H, Kondo K, Shinzato T, Kawahata M, Yamaguchi K. Absolute configuration of (+)-pinoresinol 4-O-[6-O-galloyl]-β-D-glucopyranoside, macaranga sides E, and F isolated from the leaves of Macarangatanarius. Phytochemistry 2009;70:1277-85.
  6. Puteri MG, Kawabata J. Novel α-glucosidase inhibitors from macarangatanarius leaves. Food Chem 2010;123:384-9.
  7. Elliott SS. Leim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002;76:911-22.
  8. Nugroho AE. Review: an animal model of diabetes mellitus: pathology and mechanism of some diabetogenic. Biodiversitas 2006;7:378-82.
  9. Saleh DO, El-Awdan SA, Nofel SM, El-Eraky WI, El-Khatib AS, Kenawy SA. Estrogens improve the cardiovascular alterations in fructose-induced insulin resistant ovariactoized rats. Int J Pharm Pharm Sci 2015;7:241-7.
  10. Srivastava SP, Mishra A, Lakshmi V, Tamrakar AK, Srivastava MN, Srivastava AK. Antidiabetic and antidyslipidemic activity of ethyl acetate fractions of xylocarpusgranatum and xylocarpusmolluccensis on high fructose high fat and high sucrose hig fat fed-low dosed streptozotocin-treated diabetic rats. Int J Pharm Pharm Sci 2015;7:537-43.
  11. Rashid S, Watanabe T, Sakaue T, Lewin G. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Chem Biochem 2003;36:421-9.
  12. Huang D, Dhawan T, Young S, Yong WH, Boros LG, Heaney AP. Fructose impairs glucose-induced hepatic triglyceride synthesis. Lipids Health Dis 2011;10:20.
  13. DeBosch BJ, Chen Z, Saben JL, Finck BN, Moley KH. Glucose transporter 8 (GLUT8) mediates fructose-induced de novo lipogenesis and macrosteatosis. J Biol Chem 2014; 289:10989-98.
  14. Padiya R, Khatua TN, Bagul PK, Kucha M, Banerjee SK. Garlic improves insulin sensitivity and associated metabolic syndromes in fructose-fed rats. Nutr Metab 2011;8:53.
  15. Handayani MT, Hendra P. Pengaruh pemberian ekstrak metanol-air daun Macarangatanarius L. terhadap penurunan kadar glukosa darahpada tikus yang terbebani glukosa. Jurnal Farmasi Sains dan Komunitas 2013:10:37-42.